James A. Gaudino

Clinical Associate Professor, Epidemiology



MD Medicine, University of California (Davis), 1985
MPH Epidemiology, University of California (Berkeley), 1987
MS Biostatistics, California State University, Northridge, 1980
FACPM American Board of Preventive Medicine,



Oregon Health & Science University
Dept. Public Health and Preventive Med & Gaudino Consulting, LLC
9061 SW 38th Avenue
Portland, OR 97219


Dr. Gaudino is a board-certified preventive medicine and public health physician, a senior medical epidemiologist and a senior health consultant in Portland, Oregon. He consults on a wide variety of health-related issues involving community & population-based health assessment and monitoring, patient engagement with healthcare and research; healthcare quality performance measurement & improvement; and applied health services, public health, and epidemiologic research. He currently works with OCHIN’s multi-state, PCORI-funded research consortium, called ADVANCE, conducting clinic- and practice-based research among the largest US network of clinics serving safety-net patients. His experience encompasses all sectors of public health—federal, tribal, state and local. He serves as an Affiliate and Clinical Associate Professor with the Oregon Health & Science’s (OHSU’s) Department of Public Health and Preventive Medicine and University of Washington’s Department of Epidemiology.

He is a founding and Executive Committee member of and APHA Epidemiology Section’s representative to the International Joint Policy Committee (IJPC) of the Societies of Epidemiology. He served as the Chair-elect, Chair, and Immediate Past Chair of the American Public Health Association (APHA) Epidemiology Section—one of the largest epidemiology societies in North America.

In Oregon, he led the Epidemiology Program for the Multnomah County Health Department. At Oregon’s Public Health Division, his proposals won $2.1 million to monitor the impact of the Human Papillomavirus (HPV) vaccine on precancerous cervical disease; to investigate increasing parent-signed exemptions to school immunization requirements; and to monitor immunization coverage. During his 12-year career with the CDC’s Division of Reproductive Health, he, his collaborators and students and fellows addressed a wide variety of maternal, infant, child & adolescent health (MICAH) issues. He served nine years in the Pacific Northwest at 3 state health departments and at a regional tribal health organization as CDC’s first doctoral-level assignee to regional tribal health organizations. His career began at a local county during the height of the first wave of the HIV epidemic in the San Francisco Bay area. He is a graduate of CDC’s Epidemic Intelligence Service (EIS) fellowship (1991), and he holds two master's degrees in biostatistics and epidemiology.

He is passionate about applying the science of epidemiology in partnership with communities and stakeholders to address a wide range of health issues facing diverse populations including: maternal, infant, child & adolescent health; evidence-based health care and care quality improvement; health influences over the life course; the social determinants of health and wellbeing; and chronic and communicable diseases, sexually-transmitted infections & outbreaks.  He welcomes and enjoys mentoring students and early career colleagues.

Research Interests

Maternal, infant, child, adolescent and family health; health care transformation, health care reform outcome and quality improvement research.Dr. Gaudino applies the science of epidemiology to address a wide range of health issues facing diverse populations:

  •  Maternal, infant, child, adolescent and family health (MCAH) from the life course, social determinants of health and wellbeing, and developmental origins of health and disease perspectives.
  •  Health care transformation, health reform outcome and quality improvement research including:

a) Comparing the effectiveness of healthcare and community-level health interventions.  

b) Identifying effective ways to use client-, practice- and community-level health data and evidence-based practice recommendations for quality improvement interventions, organizational decision making, and increasing client, clinician and community understanding and informed health care choices (i.e., improving patient health literacy and engagement).

c) Determining the impacts of the patient-centered primary care home (medical home) care model 

d) Developing and evaluating community health and population medicine approaches that empower patients and community members to understand, prioritize, and address their community’s health needs (i.e., increasing patient and community health literacy and engagement).

e) Identifying clinician, healthcare facility and community-level factors associated with clinician and health plan acceptance of and adherence to new evidence-based practice guidelines (e.g., immunization, pain management and opioid prescribing, early screening and detection for disease, and other treatment practice guidelines)

  • The application of epidemiologic methods in public health practice and research from design to interpretation, dissemination and translation to policy, program development, and evaluation.

No publications at this time.

In the News

No news articles at this time.